Xcout IntelSign inSubscribe

IDI SCA IDI competitors & alternatives

0I0PAsset ManagementUnited Kingdom

The 12 closest competitors and alternatives to IDI SCA IDI among asset management companies — ranked by similarity to what IDI SCA IDI actually does, not by market-cap band.

12Competitors listed

Subscribe to see IDI SCA IDI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About IDI SCA IDI

IDI is a private equity investment firm that provides capital and strategic support to small and mid-sized enterprises (SMEs and ETIs) in Europe and emerging markets. The firm specializes in LBOs and growth capital, investing in various sectors such as software, healthcare, industrial manufacturing, and consumer goods.

IDI SCA IDI at a glance

IDI SCA IDI is an asset management company headquartered in United Kingdom. Xcout tracks 6 named people at IDI SCA IDI, including Christian Langlois-Meurinne (CEO).

IDI SCA IDI leadership

  • Christian Langlois-MeurinneCEO
  • Augustin Harrel-CourtesPartner
  • Jonathan CollPartner
  • Julien BentzManaging Partner
  • Sébastien ChaigneOperating Partner
  • Tatiana NourissatCorporate Secretary and General Counsel - Responsable ESG

Top 12 IDI SCA IDI competitors

Ranked by semantic similarity — how close each company is to IDI SCA IDI by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

HBM Healthcare Investments AG0QOC · Asset ManagementZug, Switzerland
64% matchPublic

Similar asset management company

HBM Healthcare Investments AG strategically deploys capital through both direct investments and allocations to other funds, targeting middle-market and mature companies. Its investment mandate is broad, encompassing various stages from nascent startups, early-stage, mid-stage, and late-stage private ventures to emerging unlisted businesses, smaller public companies, management buyouts, growth capital opportunities, and private investments in public equities (PIPEs). Within its fund-of-funds segment, it specifically backs venture capital funds. The firm also provides financing for the spin-off of product lines or departments from larger corporations, supports the expansion or restructuring of established businesses, and participates in seed, venture, and expansion capital rounds, along with additional buyout transactions. HBM's primary focus is on private and public entities within the healthcare sector, with a strong emphasis on human medicine, pharmaceuticals (including biopharma), biotechnology, diagnostics, medical technology, and related industries. Initial investments are typically made in companies whose core products are either in clinical development or the stage immediately preceding it. The fund adopts a global investment approach, concentrating its efforts particularly on the Asia Pacific region, North America, and Europe. For publicly listed companies, HBM generally targets those that have transitioned from its private investment portfolio. The firm often increases its stake in portfolio companies by participating in subsequent financing rounds or after the company's initial public offering. HBM may acquire controlling interests in portfolio companies and frequently secures a seat on their Board of Directors. While equity investments are its predominant method, it also utilizes a range of other financial instruments, including convertible bonds, debt securities, structured products, and derivatives. HBM's primary exit strategies for its portfolio companies involve trade sales or initial public offerings.

Market cap$2B
Employees—
HBM Healthcare Investments AG competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of IDI SCA IDI and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for IDI SCA IDIand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →